EUVIMEDEUVIMED entdecken
Multizentrische Studie

Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan

Guan-Jhou Chen iD, Chien-Yu Cheng, Chia-Jui Yang, Nan-Yao Lee, Hung-Jen Tang, Sung-Hsi Huang, Miao-Hui Huang, Bo-Huang Liou, Yi-Chien Lee, Chi-Ying Lin, Tung-Che Hung, Shih-Ping Lin und 4 weitere

Journal of Antimicrobial Chemotherapy · 02.05.2024 · 79 (5) · 1157-1163

DOI: 10.1093/jac/dkae086 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 28.03.2024. Verfasst von Guan-Jhou Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Drug Resistance, Viral, Viral Load. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Centers for Diseases Control.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Monitoring the trends of pre-treatment drug resistance (PDR) and resistance-associated mutations (RAMs) among antiretroviral-naïve people with HIV (PWH) is important for the implementation of HIV treatment and control programmes. We analysed the trends of HIV-1 PDR after the introduction of second-generation integrase strand-transfer inhibitors (INSTIs) in 2016 in Taiwan, when single-tablet regimens of non-nucleoside reverse-transcriptase inhibitor (NNRTI-) and INSTI-based antiretroviral therapy became the preferred treatments. Materials and methods In this multicentre study, we included newly diagnosed, antiretroviral-naïve PWH who underwent tests for RAMs between 2016 and 2022. Pre-treatment genotypic resistance testing was performed, along with HIV-1 subtyping and determinations of plasma HIV RNA load and CD4 lymphocyte counts. RAMs were analysed using the Stanford University HIV Drug Resistance Database and only RAMs conferring at least low-level resistance were included.

Results

From 2016 to 2022, pre-treatment blood samples from 3001 newly diagnosed PWH, which constituted 24.3% of newly diagnosed PWH in Taiwan during the study period, were tested. Of the PWH with analysable gene sequences, the HIV-1 PDR prevalence to NNRTIs, nucleoside reverse-transcriptase inhibitors (NRTIs), first- and second-generation INSTIs and PIs was 10.0%, 2.1%, 2.5%, 0.6% and 0.4%, respectively. While the trends of PDR remained stable for NRTIs, INSTIs and PIs, there was a significantly increasing trend of PDR to NNRTIs from 6.0% in 2016% to 13.1% in 2022 (P = 0.001).

Conclusions

After the introduction of second-generation INSTIs in Taiwan, the trends of HIV-1 PDR to NRTIs and INSTIs remained low. Furthermore, there was no significant decrease of the prevalence of PDR toward NNRTIs between 2016 and 2022.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV InfectionsDrug Resistance, ViralViral LoadHumansTaiwanMaleFemaleAdultMiddle AgedMutationGenotypeHIV Integrase InhibitorsCD4 Lymphocyte CountAnti-HIV AgentsYoung AdultReverse Transcriptase InhibitorsRNA, Viral

Substanzen

HIV Integrase InhibitorsAnti-HIV AgentsReverse Transcriptase InhibitorsRNA, Viral

Autor:innen und Institutionen

  • Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
  • Infection Control Room, Min-Sheng General Hospital, Taoyuan, Taiwan.
  • Department of Infectious Diseases, Taoyuan General Hospital, Ministry of Health and Welfare, Taoyuan, Taiwan.
  • School of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan.
  • School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Guan-Jhou Chen, Chien-Ching Hung

Förderung

  • Centers for Diseases Control

Zitieren

APA

Chen, G. J., Cheng, C. Y., Yang, C. J., Lee, N. Y., Tang, H. J., Huang, S. H., Huang, M. H., Liou, B. H., Lee, Y. C., Lin, C. Y., Hung, T. C., Lin, S. P., Sun, H. Y., Chang, S. Y., Hung, C. C., & Taiwan HIV Study Group (2024). Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan. Journal of Antimicrobial Chemotherapy, 79(5), 1157-1163. https://doi.org/10.1093/jac/dkae086

Vancouver

Chen GJ, Cheng CY, Yang CJ, Lee NY, Tang HJ, Huang SH, et al. Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan. Journal of Antimicrobial Chemotherapy. 2024;79(5):1157-1163. doi:10.1093/jac/dkae086

BibTeX
@article{Chen2024,
  author = {Chen, Guan-Jhou and Cheng, Chien-Yu and Yang, Chia-Jui and Lee, Nan-Yao and Tang, Hung-Jen and Huang, Sung-Hsi and Huang, Miao-Hui and Liou, Bo-Huang and Lee, Yi-Chien and Lin, Chi-Ying and Hung, Tung-Che and Lin, Shih-Ping and Sun, Hsin-Yun and Chang, Sui-Yuan and Hung, Chien-Ching and Taiwan HIV Study Group, Taiwan HIV Study Group},
  title = {Trends of pre-treatment drug resistance in antiretroviral-naïve people with HIV-1 in the era of second-generation integrase strand-transfer inhibitors in Taiwan},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  volume = {79},
  number = {5},
  pages = {1157--1163},
  doi = {10.1093/jac/dkae086}
}
Kostenlos starten →